BCX-34 oral modulator of T cell proliferation: Update

Patients with early stage infection (CD4 counts >400) will be enrolled, in cohorts

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE